Anavex Life Sciences (NASDAQ:AVXL) Stock Price Passes Above Fifty Day Moving Average - What's Next?
Anavex Life Sciences (NASDAQ:AVXL) Shares Cross Above 50-Day Moving Average - Should You Sell...
MarketBeat·12d ago
More News
What's Going On With Anavex Life Sciences Stock On Wednesday?
Anavex Life Sciences' stock rises despite no news, up over 40% this year as investors watch Alzheimer's program updates and analyst targets.read more...
Benzinga·13d ago
Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?
Here is how Alcon (ALC) and Anavex Life Sciences (AVXL) have performed compared to their sector so far this year.
Zacks·15d ago
Anavex Life Sciences (NASDAQ:AVXL) Shares Cross Below 50-Day Moving Average - Here's What Happened
Anavex Life Sciences (NASDAQ:AVXL) Shares Cross Below 50-Day Moving Average - Should You Sell...
MarketBeat·20d ago
Anavex Life Sciences (NASDAQ:AVXL) Upgraded at Wall Street Zen
Wall Street Zen upgraded Anavex Life Sciences from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·1mo ago
Anavex Life Sciences (AVXL) Upgraded to Buy: Here's What You Should Know
Anavex Life Sciences (AVXL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·1mo ago
Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?
Here is how Anavex Life Sciences (AVXL) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.
Zacks·1mo ago
Q2 EPS Forecast for Anavex Life Sciences Boosted by Analyst
Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) - Investment analysts at HC Wainwright increased their Q2 2026 earnings estimates for shares of Anavex Life Sciences in a note issued to...
MarketBeat·1mo ago
Brokers Issue Forecasts for AVXL Q1 Earnings
Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) - Equities researchers at HC Wainwright issued their Q1 2027 EPS estimates for shares of Anavex Life Sciences in a note issued to investors on...
MarketBeat·1mo ago
D. Boral Capital Reiterates "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL)
D. Boral Capital reiterated a "buy" rating and set a $24.00 price objective on shares of Anavex Life Sciences in a research note on Monday...